Preserved clinical performance was also observed in individual patients with 4R-tauopathies and high tau burden but sustained dopamine transporter availability (Fig. 4b), speaking for a variable vulnerability of dopaminergic neurons in presence of 4R tau. Here, SLC6A3 is linked to tauopathy.